Gainers
- NKGen Biotech NKGN stock rose 18.0% to $2.16 during Thursday's pre-market session. The company's market cap stands at $47.2 million.
- Nutex Health NUTX stock increased by 15.32% to $0.12. The market value of their outstanding shares is at $91.9 million.
- Avinger AVGR stock moved upwards by 13.51% to $4.2. The company's market cap stands at $5.3 million.
- Exicure XCUR stock moved upwards by 12.66% to $0.74. The market value of their outstanding shares is at $6.4 million.
- Ventyx Biosciences VTYX shares rose 11.73% to $10.0. The company's market cap stands at $592.3 million.
- Lucy Scientific Discovery LSDI stock moved upwards by 11.05% to $1.91. The market value of their outstanding shares is at $3.3 million.
Losers
- Avid Bioservices CDMO stock declined by 37.4% to $5.5 during Thursday's pre-market session. The company's market cap stands at $347.8 million.
- Emergent BioSolutions EBS stock fell 16.57% to $2.72. The market value of their outstanding shares is at $141.1 million. As per the news, the Q4 earnings report came out yesterday.
- Nexalin Technology NXL stock decreased by 13.47% to $0.45. The market value of their outstanding shares is at $3.2 million.
- CASI Pharmaceuticals CASI shares declined by 10.53% to $5.27. The market value of their outstanding shares is at $70.2 million.
- Immuron IMRN shares fell 9.42% to $3.08. The company's market cap stands at $17.5 million.
- Trxade Health MEDS shares declined by 8.81% to $15.74. The company's market cap stands at $18.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CASICASI Pharmaceuticals Inc
$2.60-3.35%
CDMOAvid Bioservices Inc
$12.27-0.49%
EBSEmergent BioSolutions Inc
$8.070.12%
IMRNImmuron Ltd
$2.054.59%
NKGNNKGen Biotech Inc
$0.640013.3%
NUTXNutex Health Inc
$29.38-0.07%
NXLNexalin Technology Inc
$2.75-10.1%
VTYXVentyx Biosciences Inc
$2.24-1.75%
XCURExicure Inc
$16.907.37%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in